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By DOROTHEE WERNETf AND FRANK LILLY
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In addition to the H-2l-associated immune response genes, other genes, independent of
the H-2 complex, have been shown to play an important role in the antibody response to
certain antigens (1-3) . In particular, C57BL/10 (1310)' mice or their H-2 congenic partners
often show a lower or altered antibody response in comparison to mice of other strains
which carry the same H-2 type (4-7) . Since the most extensive collection of H-2 congenic
strains consists of the B10 series, these mice are widely used for a variety of investigations,
and any influence of the B10 background on the outcome of experiments is of great
importance.
After our investigation of the immune response genes that influence the production of
antibodies to the H-2D° alloantigens carried on the C57BL leukemia EL4 (8), experiments
were performed to compare the antibody response of B10.A(5R) mice (5R), a responder
strain to H-2D° alloantigens on EL4 cells (9), when immunized with various other H-2D°
carrying cells. The results present the surprising evidence that 5R mice produce
anti-H-2D° IgG alloantibodies only if the immunizing cell carries additional foreign cell
surface antigens. In an H-2D° congenic immunization only IgM antibodies are secreted
indicating a defect in the T-cell helper function which is responsible for the switch from
IgM to IgG production.
In order to ascertain whether the genes that regulate this differing response are
linked to H-2 or are located outside the H-2 complex, another H-2 congenic
combination of the B10 series (B10.D2 anti-B10.HTG) was compared to an H-2
identical combination of the BALB/c congenic series (BALB/c anti-
BALB.HTG) . The evidence suggests that genes, not linked to H-2, regulate this
differing antibody response to H-2D° alloantigens, but do not affect cell-medi-
ated immunity as tested by a T-cell killer assay.
* This work has been supported by contracts N01 CP 33249 and N01 CB NCI 043934 from the
National Cancer Institute.
f Supported by grant We 593/4 of the Deutsche Forschungsgemeinschaft .
'Abbreviations used in this paper: 1310, C57BL/10; CML, cell-mediated lympholysis; FCS, fetal
calf serum; 5R, B10.A(5R); LMC, lymphocyte-mediated cytolysis; MLC, mixed leukocyte culture;
PBS, phosphate-buffered saline; PEC, peritoneal exudate cells; PHA, phytohemagglutinin; 2-Me,
2-mercaptoethanol; 2R, B10.A(2R) .
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Materials and Methods
Mice andImmunizations.
￿
All animals used in the experiments reported here were from ourown
colonies of inbred mouse strains. All immunizations were directed against H-2D' alloantigens.
B10.A(5R) mice (2-6 mo old) were immunized with normal spleen cells of strains B10, A.BY, and
B10.A(2R) (2R) . The H-2 haplotypes of these mice are shown in Table I. 5R belongs to the series of
congenic strains of C57BL/10 origin (10); its H-2haplotype (H-2`b) (11) is derived from acrossover be-
tween H-2' and H-2' occurring in the I region (12). B10 and A.BY both carry the H-2' haplotype,
B10on the same background as 5R, A.BY on the genome of the unrelated strain A. 2R differs from 5R
in the H-2K, I, and D region. Immunizations of 511 with B10 cells are directed only against H-2D',
with A.BY against H-2D' and additional non-H-2 cell surface antigens, with 2R against H-2K", H-2P`,
and H-2D'.
B10.D2 mice were immunized with normal spleen cells of the H-2 congenic strain B10.HTG, and
BALB/c mice were immunized with congenic BALB.HTG normal spleen cells. B10.1)2 and BALB/c
carry the H-2° haplotype; B10.HTG andBALB.HTG carry theH-28 haplotype, which is derived from
a crossover between H-2° and H-2' occurring between the S and D region of the H-2 complex, as
shown in Table I (12). Therefore immunizations of H-2° anti-H-28 on a congenic background are
directed only against the H-2D° alloantigens since all other regions of the H-2 complex are shared by
H-2° and H-28 mice. (Regarding the possible involvement of I' genes in the H-28 haplotype see ref.
13,14).
The mice received a first inoculation of 0.5 x 10' cells injected subcutaneously; 2 wk later 5 x 108
cells were injected intraperitoneally, and the immunization wascontinued with biweekly intraperito-
neal injections of 10 x 10' cells. Theimmunized mice were bled from the retroorbital plexus at various
intervals after each injection. All antisera were stored at -70'C until tested. Target cells in assays for
antibody determination or cell-mediated cytotoxicity were chosen from various H-2D' strains:
HTH/Go, HTG/Go, BALB/c-H-2', B10.A(4R), D2.GD, and the H-2D' strains shown in Table I.
Antibody Determinations.
￿
For the complement-mediated cytotoxicity test for antibody activity
(15, 16), H-2D'-carrying lymph node cells were incubated with 0.1 mC "Cr (Sodium Chromate
100-300 mC/mg, Amersham/Searle Corp., Arlington Heights, Ill.) for 2-3 h. 1 x 10' labeled and
washed target cells were mixed with guinea pig complement (Grand Island Biological Co., Grand
Island, N.Y.) and twofold dilutions of antiserum in a final vol of 0.3 ml of Medium 199
(Microbiological Associates, Inc., Bethesda, Md.) supplemented with 20%FCS (GIBCO). After 1 hof
incubation at room temperature the reaction was terminated by adding 0.3 ml of a cold EDTA-PBS
solution, the cells were then centrifuged and 0.3 ml of supernate taken off for determination of "Cr
release. The results are expressed as percent killing, 100% being defined as the counts per minute
(minus the spontaneous release) contained in 0.3 ml of supernate of labeled cells that have been
frozen andthawed four times.
TABLE I
H-2 Haplotype of the Mouse Strains Used
Vertical bars indicate the site of crossover. The crossover in B10.A(5R)
occurred inside the I region, between IB andIC (12) . The Is antigens of
B10 mice, as known so far, are shared by 511 and therefore do not present
any additional cell surface antigens. Regarding the possible involvement
of I' genes in the H-2 8 haplotype, see ref. 13, 14.
H-2complex
K I S D
B10.A(5R) [H-2"] b b d d
B10; A.BY [H-2'] b b b b
B10.A(2R) [H-2"s] k k d I b
B10.D2; BALB/c [H-2'1 d d d d
B10.HTG; BALB.HTG [H-28 ] d d d bDOROTHEE WERNET AND FRANK LILLY
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Hemagglutination tests were performed on redblood cells obtained by eye bleeding into isotonic
sodium citrate solution; the cells were washed once in saline and resuspended in a mixture of two
parts heat-inactivated FCS and one part saline solution at an estimated concentration of 10'/ml .
Antisera were prepared in serial twofolddilutions in dextran (mol wt 115,000) 1.8-2.0% in 6% glucose
solution. One drop of antiserum dilution was added to one drop of red blood cell suspension in
disposable plastic trays and incubated for 90 min at 37°C. The degree of hemagglutination was
determined by examining the extent of clumping by low power microscopy. This method is that of
Gorer and Mikulska (17) with minor modifications. Disulfide bond reduction of the H-2 antibodies
with 2-mercaptoethanol (2-Me) was carried out by incubating sera with 0.1 M 2-Me in a 1:1 mixture
for 30 min at 37°C as described by Klein et al. (18).
Lymphocyte-Mediated Cytolysis (LMC). The LMC was performed following the method of
Berkeet al. (19) . Peritoneal exudate cells (PEC) from immunized mice were harvestedby flushing the
peritoneal cavity on the fourth or fifth dayafterthe immunization. As target cells C57BL leukemia
cells (EL4, H-2°) (20) or phytohemagglutinin (PHA)-induced blasts of different mouse strainswere
used. PHAblasts were obtained by incubation o£ mouse spleen cells with PHA (WellcomeResearch
Laboratories, Beckenham, England) (1:100) for 3 days. 5 x 10' labeled target cells in 0.1 ml were
added to 1 x 10'PEC in 1.0 ml andincubated at 37 °C on arocking plate (BellcoGlass, Inc., Vineland,
N. J.) at sixrocks perminute. Allsampleswere setup in duplicateor triplicate.Aftervarious times of
incubation thecells were centrifuged andan aliquot of the supernate takenfor determination of "Cr
release. Duplicatesamplesof5x 10'target cells in 1.1 ml of medium withoutanyeffector cellsserved
to determine the total releasable radioactivity (supernate of cells frozen andthawed four times) and
the spontaneous release. The percent killing was calculated as described in the antibody-comple-
ment-mediated cytotoxicity test.
To demonstrate thenature of the killer cells in the LMC the PEC were treated with anti-Thy-1.2
serum and complement following the method of Katz and Osborne (21) . Anti-Thy-1 .2 serum was
obtained by immunizing AKR mice with C3H/An thymocytes in a modification of the method
described by Cerottini et al. (22). To test the participation of macrophages in the LMC they were
removed from thePEC by incubation ofthe cell suspension in a Sephadex G-10-column (Pharmacia
Fine Chemicals, Uppsala, Sweden) for 30 min at 37°C (23).
Results
The Antibody Response of 5R Mice to H-2D° Alloantigens.
￿
511 mice were
immunized against H-2D° alloantigens carried on three different strains ofmice,
1310, A.BY, and 2R. When the antibody response was measured in the comple-
ment-mediated cytotoxicity test only anti-A.BY and anti-2R yielded detectable
levels of anti-H-2Db cytotoxicity whereas immunization of 511 mice with normal
B10 spleen cells produced either a very low or negative response (Fig. 1).
When the antibodies were tested in the hemagglutination test, a similar but
not identical picture evolved as shown in Table II. After five immunizations 511
anti-1310 showed a low titer of 1:128 in the hemagglutination test, comparable to
the titers obtained by Stimpfling and Durham in an identical immunization (24)
whereas 511 anti-A.BY and anti-2R yielded higher titers (1:1,024 and 1:512).
In order to determine the nature of the antibody involved the sera were
incubated with 0.1 M 2-Me for 30 min. This treatment inactivates IgM
antibodies but does not inhibit the activity of IgG antibodies . As can be seen in
Table II, treatment with 2-Me totally abolished the anti-H-2D° response in the
5R anti-1310 combination whereas the titers remained unchanged in the other two
combinations .
Cell-Mediated Immunity in 5R Mice Immunized with B10 Spleen Cells.
￿
To
test the cell-mediated response of 511 mice that had been injected with spleen
cells from congenic B10 mice and had not produced detectable cytotoxic
antibodies, a "Cr release assay was used with EL4 cells as targets. Preliminary576
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FIG . 1.
￿
Antibody levels as measured by a complement-mediated "Crreleasecytotoxic-
ity assay. Titration on H-2D° (B10) lymph node cells of sera collected from 5R mice 7
days after the fifth immunization with spleen cells of A.BY, 2R, and B10 mice.
TABLE 11
Antibody Response AfterFive Immunizations of B10.A(5R) Mice Immunized With Cells
Carrying H-2D° Alloantigens
Titers in thehem-
agglutinationtest
after treatmentof
the sera with 2-Me
0
1:1,024
1:512
experiments had shown that PEC were more effective as killer cells than spleen
or lymph node cells, confirming results described by Berke et al. (19). Therefore
PEC were used for all experiments. PEC were harvested 4 or 5 days after each
immunization, and the mice were bled the same day. The sera were tested for
cytotoxic antibody activity and were consistently found to be negative. Fig. 2
represents the results of the LMC tests performed after each immunization . No
cell-mediated killing during 6 h of incubation was observed after the first immuni-
zation. After the second inoculation a positive cytotoxic response was seen; sub-
sequent to the fourth immunization this response increased to 70-80% lysis in 4
h.
To determine the specificity of the reaction for H-2D' LMC tests were
performedwith PHA blasts ofvarious mouse strains carrying H-2D° alloantigens.
No killing reaction of PEC from 5R mice, immunized with B10 cells, could be
obtained on any PHA blasts used. These negative results confirm in vivo the
experiments performed in vitro by Festenstein et al. (25); these authors pre-
sented evidence that 5R cells responding in MLC to B10 cells do not kill B10
Cell surface Anti-H-2D°anti- Titers in
Immunizing antigens in body response in thehem-
cells addition to thecytotoxicity agglutina-
H-2D° test tion test
1310 Low 1:128
A.BY Non-H-2cell High 1:1,024
surface antigens
BlO.A(2R) H-2K; H-2l High 1:512W
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￿
Lymphocyte-mediated cytolysis during 6 h of incubation of peritoneal exudate
cells from 511 mice immunized intraperitoneally with 20 x 10" B10 spleen cells . (LMC
assays performed after the immunization schedule described in Materials and Methods
gave the same pattern.) Target cells : EL4 leukemia cells. Killer to target cell ratio, 20:1.
The first number refers to the number of immunizations, the second number to the day
after each immunization on which the PEC were harvested.
PHA blasts in a subsequent CML. We therefore tested the specificity of 5R anti-
B10 PEC on a tumor cell line of DBA/2 (H-2d) origin (P815; a gift from Dr. B.
Bloom, Albert Einstein College of Medicine, Bronx, N.Y.). P815 cells were not
lysed by PEC from 5R mice immunized with normal B10 spleen cells. Experi-
ments performed with PEC from unimmunized mice were also negative.
To examine the participation of lymphocytes and macrophages in this
cell-mediated cytotoxicity two experiments were performed. PEC were incubated
in a Sephadex G-10-column for 30 min to remove the macrophages. The reaction
remained unchanged, which suggests that macrophages are not the basis for the
cytotoxicity. Similar results were obtained by Berke et al. (19). In another
experiment PEC were treated with anti-Thy-1.2 serum (AKR anti-C3H normal
thymus cell) or normal AKR serum and complement before incubation with the
target cells. Treatment with normal AKR serum only slightly diminished the
number of PEC and did not change the cell-mediated reaction, whereas
treatment with anti-Thy-1.2 serum lysed approximately 40% of the PEC and
completely abolished the killing reaction (Fig. 3). This indicates that the cells
reactive in this assay are Thy-l-carrying T cells (19).
Comparison of the Antibody Response of B10.D2 to B10.HTG and of BALB/c
to BALB.HTG. In order to determine whether the low response of 5R mice
immunized with congenic B10 cells is a feature specific for 5R or is shared by
other strains of the C57BL/10 series, an immunization of another B10 congenic
strain, B10.D2 anti-BIO.HTG, was performed. 1310.132 carries the same H-2Sand
H-213 regions as 5R; it differs from B10.HTG at the H-213 region only. This
immunization was compared to an H-2 identical combination on the BALB/c
background, BALB/c anti-BALB.HTG. Any difference between the B10.D2 and
BALB/c sera cannot be attributed to the H-2 complex.578
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FIG. 3.
￿
Lymphocyte-mediated cytolysis 5 days after the fourth immunization of 5R
mice with B10 cells. Target cells: EL4 leukemia cells. Killer to target cell ratio, 20:1.
("---"), untreated PEC; (A---A), PEC treated with normal AKR serum and comple-
ment; (O---O), PEC treated with anti Thy-1 .2 serum and complement.
In the complement-mediated cytotoxicity test only very low or negative
antibody titers were found in the B10.D2 anti-B10.HTG sera, whereas the titers
in the BALB/c anti-BALB.HTG sera were significantly higher. Titers of the
bleedingsobtained after three and five injections are shown in Fig. 4. 7 days after
the third immunization the B10.D2 anti-B10.HTG sera showed no cytotoxic
antibodies, whereas the sera ofthe BALB/c combination exhibited 60% killingat
a 1:5 dilution. 7 days after the fifth immunization the situation was virtually
unchanged: 50% killing with theBALB/c sera and only 13% at a 1:5 dilution with
the B10.D2 sera. Sera tested after several further injections showed an identical
pattern.
When tested by hemagglutination, the same pattern could be seen as in the
cytotoxicity test: high titers in the BALB/c sera and low titers in the B10.D2 sera
(Table III). 7 days after the fifth immunization the BALB/c sera reached a titer
of 1:512 in comparison to 1:128 in the B10.D2 sera.
Treatment of the sera with 2-Me completely abolished the reaction in the
B10.D2 anti-B10.HTG sera, as in the case of 511 anti-1310, but 2-Me treatment
only decreased the level of response from 1:512 to 1:128 in the BALB/c
anti-BALB.HTG sera. This strongly suggests that the anti-H-2D° antibodies of
the B10.D2 sera are exclusively ofIgM type whereas the BALB/c seracontain IgG
antibodies to H-2D° alloantigens. Thus the antibody response of B10.D2 is
similar to the response of 5R, whereas the immunization of BALB/c mice yields
an antibody reaction different from B10.D2.
Comparison of the Cell-Mediated Immunity of B10.D2 to B10.HTG and of
BALB/c to BALB.HTG. The LMC assay was performed to investigate the
cell-mediated immunity of B10.D2 and BALB/c mice immunized with H-29 cells
of the corresponding congenic series. In contrast to the 5R response, PEC from
both combinations tested here were able to lyse H-2D° carrying PHA blast cells.
Therefore in addition to EL4 leukemia cells PHA blasts ofvarious mouse strains70 r-
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￿
Antibody levels as measured by acomplement-mediated "Crrelease cytotoxic-
ity assay. Titration on H-2D" (2R) lymph node cells of sera collected 7 days after the
third (3) and fifth (5) injections.
TABLE III
Comparison of the Antibody Response of B10.D2 anti-BIO.HTG and BALE/c anti-
BALB.HTG after 5 Immunizations
Anti-H-2D°anti-
￿
Titers in
￿
Titers in thehem-
body response in
￿
thehem-
￿
agglutination test
thecytotoxicity
￿
agglutina-
￿
aftertreatmentof
test
￿
tion test
￿
thesera with 2-Me
B10.D2 anti-B10.HTG
￿
Low
￿
1:128
￿
0
BALB/c anti-BALB.HTG
￿
High
￿
1:512
￿
1:128
were used as target cells. The results of LMC tests after two, three, five, and
seven injections are shown in Table IV. Afterthe second immunization PEC from
neither MOM nor BALB/c mice lysed "Cr labeled PHA blasts with H-2D°
alloantigens, but PEC from the BALB/c immunization did lyse EL4 target cells
up to 40%. This confirms the findings in 5R mice that tumor cells are more
readily killed than PHA blasts . After three immunizations both EL4 cells and
PHA blasts were killed by PEC from either MOM or BALB/c mice although the
MOM response was weaker. After further injections there was virtually no
difference in the killing capacity of cells from MOM and BALB/c mice
immunized with H-29 cells of the corresponding congenic series.
Using PHA blasts from various strains of mice carryingthe H-2D° alloantigens
(HTH/Go, HTG/Go, C57BL/6) it was shown that the T-cell response was specific
for H-2D'; the PEC did not lyse H-2k (AKR) PHA blasts as shown in Table IV.
To confirm that the effector cells in the LMC are still T cells, even after seven
immunizations, half of the PEC were treated with anti-Thy-1 .2 serum and
complement before incubation with the target cells. As can be seen in the last580
￿
GENETIC REGULATION OF T-CELL HELPER FUNCTION
TABLE IV
Lymphocyte-Mediated Cytolysis of PEC Harvested 4 Days After Each Immunization
(Killer to Target Cell Ratio, 20:1)
* PEC treated with anti Thy-1.2 + C'.
$a = B10.D2 anti-BIO.HTG; b = BALB/c anti-BALB.HTG.
"Crrelease
column of Table IV the killing capacity of the effector cells was abolished by this
treatment, indicating that after seven immunizations the killer cells in both
strains were still of T-cell origin.
Discussion
The experiments reported here have shown that 5R mice immunized with B10
spleen cells respond to H-2D' alloantigens with low levels of antibodies of IgM
type only. T cells from these mice reveal a normal cell-mediated immunity; they
are able to recognize the H-2D' difference and kill EL4 (H-2D°) leukemia cells.
On the other hand, 5R mice immunized with cells carrying alloantigen specifici-
ties in addition to H-2D' (non-H-2 alloantigens in the case of A.BY, H-2K, and
H-2I antigens in the case of 2R) produce IgG antibodies to H-2D'.
McKenzie and Snell (5) have reported that BIO.A anti-BIO .AKM x B10 and
B10.AKM anti-1110A yield no or only a very weak antibody response to H-2D
antigens whereas similar congenic combinations on a background different from
B10 give a good antibody response . This is confirmed in our findings that BALB/c
mice immunized with BALB.HTG cells yield IgG antibodies to H-2D' whereas
B10.D2 anti-B10.HTG does not produce anti-H-2D' IgG antibodies . These
findings indicate that the low response of 511 anti-B10 and B10.D2 anti-B10.HTG
is not due to the H-2 complex itself but is governed by a gene or genes separate
from H-2 on the B10 background. Under the influence of these genes there is no
IgG response to H-2D' antigens unless the immunizing cells carry additional
foreign cell surface antigens .
It has been shown by Klein et al. (18) that the IgM response to H-2 is thymus
independent whereas the IgG response is thymus dependent. On the basis of
these findings the following hypothesis is proposed : for mice of the B10 series
H-2D' alloantigens, presented on a congenic background without additional
foreign cell surface antigens, constitute a "hapten" on a nonimmunogenic carrier.
This "hapten" elicits a thymus-independent IgM response only, as has been
demonstrated in another system with autologous red blood cells as nonimmuno-
genic carriers (26-27). The nonimmunogenic carrier fails to activate the T-cell
No. of immunizations
Target cells
2
a$ b
3
a b
5
a b
7
a b a
7*
b
EL4 (C57BL leukemia) -3.6 40.1 30.8 52.3 73.8 66.6 74.2 62.4 -2 .5 5 .8
H-2D"PHA blasts -17.2 3.0 16.1 31 .9 ND ND 38.6 45.0 -13.6 -17.4
H-2'p PHAblasts -4.8 -4.3 -6.7 -5.7 ND ND ND ND ND NDDOROTHEE WERNET AND FRANK LILLY
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helper function which switches the initial IgM antibody production to the IgG
response, whereas additional foreign cell surface antigens convert the nonimmu-
nogenic carrier into an immunogenic carrier that elicits an IgG response. Genes
separate from H-2 regulate the carrier recognition of T cells and thereby
influence the activation of the T-cell helper function .
In BALB/c mice these genes enable the T cells to recognize cells with only an
H-2D° difference; the T-cell helper function is activated and leads to the switch
from IgM to IgG production . In mice of B10 origin either there is no recognition
by T helper cells of cells that differ only at H-2D', or there is recognition by some
subset of T cells that does not lead to activation of T-cell helper function.
Our experiments clearly show activation of T-cell killer function in all mice
immunized with H-2D° bearing cells. Therefore the genes that are responsible for
the low response of IgM type in mice of the B10 series are not involved in the
regulation of the T-cell-mediated cytotoxicity to H-2D' antigens on congenic
cells.
In the light of this hypothesis our experiments suggest separate genetic
regulation and activation of T-cell helper function and T-cell-mediated cytotox-
icity. A separation of humoral and cellular immunity has been described by
several other groups in different experimental systems (28-30).
Summary
B10.A(5R) mice immunized with C57BL/10 spleen cells demonstrate a normal
T-cell-mediated cytotoxicity to H-2D' tumorcells but they do not mountany IgG
antibody response to H-2D' alloantigens. B10.A(5R) mice do show a high titered
IgG response when immunized with A.BY cells, which differ at H-2D' plus
non-H-2 cell surface antigens, or with B10.A(2R) cells, which differ at H-2D',
H2Kk, and H-2I' cell surface antigens. These findings indicate a failure of the
T-helper cells to induce the switch from IgM to IgG when the H-2D' alloantigens
are the only difference on the immunizing cell .
In immunizing H-2d mice with congenic H-29 cells which differ only in the
H-2D' region, mice of the C57BL/10 background made only IgM antibodies
whereas mice of the BALB/c background made IgG antibodies. This comparison
confirms that genes separate from H-2 regulate the T-cell helper function . The
genes that influence the T-cell helper function do not regulate the T-cell-
mediated cytotoxicity .
The authors express their appreciation to Holly Hoffman for excellent technical assistance and to
Harriel Martinez for expert animal care.
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